AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 26-50/56
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness
Authors: Stuyver, L De Gendt, S Van Geyt, C Zoulim, F Fried, M Schinazi, RF Rossau, R
Citation: L. Stuyver et al., A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, J GEN VIROL, 81, 2000, pp. 67-74
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S - Template interactions influencesubstrate recognition at the polymerase active site
Authors: Klarmann, GJ Smith, RA Schinazi, RF North, TW Preston, BD
Citation: Gj. Klarmann et al., Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S - Template interactions influencesubstrate recognition at the polymerase active site, J BIOL CHEM, 275(1), 2000, pp. 359-366
Synthesis of novel 3 '-C-methyl-apionucleosides: an asymmetric construction of a quaternary carbon by Claisen rearrangement
Authors: Hong, JH Gao, MY Choi, YS Cheng, YC Schinazi, RF Chu, CK
Citation: Jh. Hong et al., Synthesis of novel 3 '-C-methyl-apionucleosides: an asymmetric construction of a quaternary carbon by Claisen rearrangement, CARBOHY RES, 328(1), 2000, pp. 37-48
Synthesis of 2 ',3 '-dideoxy-3 '-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol
Authors: Chun, BK Schinazi, RF Cheng, YC Chu, CK
Citation: Bk. Chun et al., Synthesis of 2 ',3 '-dideoxy-3 '-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol, CARBOHY RES, 328(1), 2000, pp. 49-59
5-phenylthioacyclouridine: A potent and specific inhibitor of uridine phosphorylase
Authors: el Kouni, MH Goudgaon, NM Rafeeq, M Al Safarjalani, ON Schinazi, RF Naguib, FNM
Citation: Mh. El Kouni et al., 5-phenylthioacyclouridine: A potent and specific inhibitor of uridine phosphorylase, BIOCH PHARM, 60(6), 2000, pp. 851-856
Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitorof uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2 '-deoxyuridine against murine colon tumor C26-10
Authors: Ashour, OM Naguib, FNM Goudgaon, NM Schinazi, RF el Kouni, MH
Citation: Om. Ashour et al., Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitorof uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2 '-deoxyuridine against murine colon tumor C26-10, BIOCH PHARM, 60(5), 2000, pp. 687-692
Laboratory safety considerations
Authors: Feorino, PM Williamson, JD Schinazi, RF
Citation: Pm. Feorino et al., Laboratory safety considerations, METH MOL M, 24, 2000, pp. 13-25
Stavudine resistance: an update on susceptibility following prolonged therapy
Authors: Lin, PF Gonzalez, CJ Griffith, B Friedland, G Calvez, V Ferchal, F Schinazi, RF Shepp, DH Ashraf, AB Wainberg, MA Soriano, V Mellors, JW Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28
1-(Ethoxymethyl)-6-(phenylselenyl)-5-ethyl uracil: a nucleoside analog
Authors: Mazumder, G De, M Mukhopadhyay, A Das, AK Mazumder, SK Bertolasi, V Schinazi, RF
Citation: G. Mazumder et al., 1-(Ethoxymethyl)-6-(phenylselenyl)-5-ethyl uracil: a nucleoside analog, J CHEM CRYS, 29(7), 1999, pp. 837-839
Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides
Authors: Mourier, NS Eleuteri, A Hurwitz, SJ Tharnish, PM Schinazi, RF
Citation: Ns. Mourier et al., Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides, BIO MED CH, 7(12), 1999, pp. 2759-2766
Cell-based and animal models for hepatitis B and C viruses
Authors: Schinazi, RF Ilan, E Black, PL Yao, XJ Dagan, S
Citation: Rf. Schinazi et al., Cell-based and animal models for hepatitis B and C viruses, ANTIVIR CHE, 10(3), 1999, pp. 99-114
Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP
Authors: Feng, JY Shi, JX Schinazi, RF Anderson, KS
Citation: Jy. Feng et al., Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP, FASEB J, 13(12), 1999, pp. 1511-1517
Pharmacokinetics of (-)beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys
Authors: Chen, HC Schinazi, RF Rajagopalan, P Gao, ZL Chu, CK McClure, HM Boudinot, FD
Citation: Hc. Chen et al., Pharmacokinetics of (-)beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys, AIDS RES H, 15(18), 1999, pp. 1625-1630
New classes of fluorinated L-nucleosides; Synthesis and antiviral activity
Authors: Lee, K Choi, Y Hong, JH Schinazi, RF Chu, CK
Citation: K. Lee et al., New classes of fluorinated L-nucleosides; Synthesis and antiviral activity, NUCLEOS NUC, 18(4-5), 1999, pp. 537-540
Synthesis and biological evaluation of new enantiomers of 5-o-carboranyl pyrimidine nucleosides
Authors: Mourier, N Eleuteri, A Schinazi, RF
Citation: N. Mourier et al., Synthesis and biological evaluation of new enantiomers of 5-o-carboranyl pyrimidine nucleosides, NUCLEOS NUC, 18(4-5), 1999, pp. 575-576
Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replication
Authors: Faraj, A Placidi, L Perigaud, C Cretton-Scott, E Gosselin, G Martin, LT Pierra, C Schinazi, RF Imbach, JL Sommadossi, JP
Citation: A. Faraj et al., Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replication, NUCLEOS NUC, 18(4-5), 1999, pp. 987-988
Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5 ' monophosphate prodrugs and effectiveness in combination with lamivudine.
Authors: Loi, AG Faraj, A Pierra, C Gosselin, G Imbach, JL Locarnini, SA Groman, EV Schinazi, RF Sommadossi, JP
Citation: Ag. Loi et al., Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5 ' monophosphate prodrugs and effectiveness in combination with lamivudine., NUCLEOS NUC, 18(4-5), 1999, pp. 1005-1006
Synthesis of 2 ',3 '-dideoxy-2 '-fluoro-L-threo-pentafuranosyl nucleosidesas potential antiviral agents
Authors: Cavalcanti, SCH Xiang, XJ Newton, MG Schinazi, RF Cheng, YC Chu, CK
Citation: Sch. Cavalcanti et al., Synthesis of 2 ',3 '-dideoxy-2 '-fluoro-L-threo-pentafuranosyl nucleosidesas potential antiviral agents, NUCLEOS NUC, 18(10), 1999, pp. 2233-2252
A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2 ',3 '-dideoxy-3 '-thiacytidine
Authors: Smith, RA Klarmann, GJ Stray, KM von Schwedler, UK Schinazi, RF Preston, BD North, TW
Citation: Ra. Smith et al., A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2 ',3 '-dideoxy-3 '-thiacytidine, ANTIM AG CH, 43(8), 1999, pp. 2077-2080
Pharmacokinetics of beta-L-2 ',3 '-dideoxy-5-fluorocytidine in rhesus monkeys
Authors: Martin, LT Cretton-Scott, E Schinazi, RF Zhou, XJ McClure, HM Mathe, C Gosselin, G Imbach, JL Sommadossi, JP
Citation: Lt. Martin et al., Pharmacokinetics of beta-L-2 ',3 '-dideoxy-5-fluorocytidine in rhesus monkeys, ANTIM AG CH, 43(4), 1999, pp. 920-924
A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)
Authors: Lerma, JGG Schinazi, RF Juodawlkis, AS Soriano, V Lin, YL Tatti, K Rimland, D Folks, TM Heneine, W
Citation: Jgg. Lerma et al., A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC), ANTIM AG CH, 43(2), 1999, pp. 264-270
Pharmacokinetics of the antiviral agent beta-D-2 ',3 '-didehydro-2 ',3 '-dideoxy-5-fluorocytidine in rhesus monkeys
Authors: Ma, L Hurwitz, SJ Shi, JX McAtee, JJ Liotta, DC McClure, HM Schinazi, RF
Citation: L. Ma et al., Pharmacokinetics of the antiviral agent beta-D-2 ',3 '-didehydro-2 ',3 '-dideoxy-5-fluorocytidine in rhesus monkeys, ANTIM AG CH, 43(2), 1999, pp. 381-384
Nucleic acids and nucleosides containing carboranes
Authors: Lesnikowski, ZJ Shi, JX Schinazi, RF
Citation: Zj. Lesnikowski et al., Nucleic acids and nucleosides containing carboranes, J ORGMET CH, 581(1-2), 1999, pp. 156-169
Synthesis and anti-HIV and anti-HBV activities of 2 '-fluoro-2 ',3 '-unsaturated L-nucleosides
Authors: Lee, KY Choi, YS Gullen, E Schlueter-Wirtz, S Schinazi, RF Cheng, YC Chu, CK
Citation: Ky. Lee et al., Synthesis and anti-HIV and anti-HBV activities of 2 '-fluoro-2 ',3 '-unsaturated L-nucleosides, J MED CHEM, 42(7), 1999, pp. 1320-1328
Synthesis and biological evaluation of 2 ',3 '-didehydro-2 ',3 '-dideoxy-5-fluorocytidine (D4FC) analogues: Discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase
Authors: Shi, JX McAtee, JJ Wirtz, SS Tharnish, P Juodawlkis, A Liotta, DC Schinazi, RF
Citation: Jx. Shi et al., Synthesis and biological evaluation of 2 ',3 '-didehydro-2 ',3 '-dideoxy-5-fluorocytidine (D4FC) analogues: Discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase, J MED CHEM, 42(5), 1999, pp. 859-867
Risultati: 1-25 | 26-50 | 51-56